Investor mix
15 investors on record; lead investors include Cambrian BioPharma, Apeiron Investment Group, Catalio Capital Management, MedImmune; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 40% |
| Private equity | 1 | 7% |
| Accelerator & incubator | 1 | 7% |
| Other / undisclosed | 7 | 47% |